• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

Methyl 2-acetamido-5-iodobenzoate (CAS No. 208659-18-1): A Comprehensive Overview

Methyl 2-acetamido-5-iodobenzoate (CAS No. 208659-18-1) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds promise in various applications, including the development of novel therapeutic agents and as a key intermediate in synthetic pathways. This comprehensive overview aims to provide an in-depth understanding of Methyl 2-acetamido-5-iodobenzoate, its chemical properties, synthesis methods, and potential applications.

The chemical structure of Methyl 2-acetamido-5-iodobenzoate is defined by a benzoate core with an acetamido group at the 2-position and an iodine substituent at the 5-position. The presence of these functional groups imparts distinct chemical and physical properties to the molecule, making it a valuable building block in organic synthesis. The acetamido group enhances the molecule's solubility and reactivity, while the iodine substituent provides a versatile handle for further functionalization through various chemical transformations.

Recent advancements in synthetic chemistry have led to the development of efficient and scalable methods for the synthesis of Methyl 2-acetamido-5-iodobenzoate. One such method involves the reaction of 5-iodosalicylamide with methyl chloroformate in the presence of a base, followed by acetylation to introduce the acetamido group. This approach offers high yields and excellent purity, making it suitable for large-scale production. Another notable method involves palladium-catalyzed cross-coupling reactions, which have been successfully employed to introduce the iodine substituent onto the benzoate framework with high regioselectivity.

In the realm of medicinal chemistry, Methyl 2-acetamido-5-iodobenzoate has shown promise as a lead compound for the development of novel drugs. Its unique structure allows it to interact with various biological targets, including enzymes and receptors, making it a valuable starting point for drug discovery efforts. For instance, studies have demonstrated that derivatives of Methyl 2-acetamido-5-iodobenzoate exhibit potent inhibitory activity against specific kinases, which are implicated in various diseases such as cancer and inflammatory disorders. These findings highlight the potential of this compound as a scaffold for designing selective and potent inhibitors.

Beyond its direct therapeutic applications, Methyl 2-acetamido-5-iodobenzoate serves as a crucial intermediate in the synthesis of more complex molecules. Its iodine substituent can be readily converted into other functional groups through well-established chemical transformations, such as Suzuki-Miyaura coupling or Sonogashira coupling reactions. These reactions enable the introduction of diverse substituents onto the benzoate core, thereby expanding the scope of potential applications. For example, researchers have utilized Methyl 2-acetamido-5-iodobenzoate as a key intermediate in the synthesis of bioactive compounds with anti-inflammatory and anti-cancer properties.

The physical properties of Methyl 2-acetamido-5-iodobenzoate are also noteworthy. It is a white crystalline solid with good thermal stability and solubility in common organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). These properties make it easy to handle and process in both laboratory and industrial settings. Additionally, its stability under various reaction conditions ensures consistent performance during synthetic transformations.

In conclusion, Methyl 2-acetamido-5-iodobenzoate (CAS No. 208659-18-1) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure, efficient synthesis methods, and diverse applications make it an attractive target for further investigation and development. As research continues to advance, it is likely that new insights into the properties and uses of this compound will emerge, further solidifying its importance in the scientific community.

• 1131587-16-0(Methyl 2-butyramido-5-iodobenzoate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)